Pricing Log in Create free account

CG Oncology, Inc. (CGON) vs Kodiak Sciences Inc. (KOD)

CG Oncology, Inc. and Kodiak Sciences Inc. are both Biotechnology companies. CG Oncology, Inc. and Kodiak Sciences Inc. are of similar size ($5.5B and $5.5B). Kodiak Sciences Inc. has the higher net margin (0.00% vs −3,602.7%) and the higher return on invested capital (0.00% vs −4,111.6%). Across the 14 metrics below, Kodiak Sciences Inc. leads on 9 and CG Oncology, Inc. on 5.

Valuation

Metric CGON KOD Biotechnology median
P/E n/m n/m 8.50
P/S 846.74 n/m 9.71
P/B 5.12 87.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 683.55 n/m 9.21
Earnings yield (4.50%) (4.89%) (33.15%)
Free cash flow yield (3.40%) (2.98%) (25.50%)

Profitability

Metric CGON KOD Biotechnology median
Gross margin (85.20%) 0.00% 65.16%
Operating margin (4,056.18%) 0.00% 0.00%
Net margin (3,602.68%) 0.00% 0.00%
Free cash flow margin (2,879.62%) 0.00% 0.00%
Return on equity (26.41%) (368.37%) (56.36%)
Return on assets (25.11%) (94.25%) (48.04%)
Return on invested capital (4,111.64%) 0.00% 0.00%

Growth

Metric CGON KOD Biotechnology median
Revenue growth (TTM) 840.79% — 6.02%
EPS growth (last fiscal year) (47.52%) (28.96%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CGON KOD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 22.22 2.49 4.72
Net debt to EBITDA 3.88 1.01 0.96

Dividend

Metric CGON KOD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGON KOD Biotechnology median
Market cap 5.48b 5.54b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack